Gold-catalyzed chemical reaction advances next-generation anticancer prodrugs
Anticancer prodrugs have attracted significant attention from the medical and scientific communities in recent years because of their potential to improve treatment precision while reducing side effects. These drugs are engineered to remain inactive until they are activated at sp
Anticancer prodrugs have attracted significant attention from the medical and scientific communities in recent years because of their potential to improve treatment precision while reducing side effects. These drugs are engineered to remain inactive until they are activated at sp This story matters for Science & Discovery readers tracking inventors. Reported by phys.org. Read the full original at the source link below.
Originally reported by phys.org. InventorsNews curates and briefs the science & discovery stories that matter. Our editorial policy →